Neuroone Medical Technologies is trading 6.8% down at $1.77 today as the stock continues to face downward pressure following last week’s brief rebound.
- There are no fresh company-specific headlines, earnings, FDA decisions, or analyst calls today to justify the move.
- The decline appears to be a continuation of recent weakness and profit-taking in the thinly traded micro-cap name.
- The price action occurs against a backdrop of mixed broader markets, which often impacts speculative micro-cap stocks.